Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L

scientific article published on 01 April 2000

Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1045801502
P356DOI10.1038/MODPATHOL.3880076
P698PubMed publication ID10786813

P2093author name stringSigel JE
Hsi ED
P2860cites workDifferences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotypeQ70496921
Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomasQ70789099
Fas ligand and immune evasionQ71840940
Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patientsQ72953743
Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 casesQ73186852
Apoptotic and proliferating cells in cutaneous lymphoproliferative diseasesQ73543128
Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expressionQ73981632
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor familyQ28285445
The Fas death factorQ29620461
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunityQ33488225
Fas and Fas ligand: lpr and gld mutationsQ40398275
Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatmentQ40854148
Fas and FasL in the homeostatic regulation of immune responsesQ40957267
Downregulation of Fas ligand by sheddingQ41071790
Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour linesQ42651249
A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.Q53462456
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeQ55670225
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project GrouQ57786781
Cutaneous CD30+ lymphoproliferative disorders: Expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamilyQ58482188
Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 casesQ68456240
A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphomaQ70470137
P433issue4
P921main subjectimmunohistochemistryQ899285
lymphoproliferative disordersQ4165484
P304page(s)446-451
P577publication date2000-04-01
P1433published inModern PathologyQ15724578
P1476titleImmunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L
P478volume13

Search more.